News
We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Investor's Business Daily on MSN21h
Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback